Seven decades of angiotensin (1939–2009)

R Skrbic, R Igic - Peptides, 2009 - Elsevier
Two research groups in both North and South America independently discovered that renin
released a novel vasopressor agent. The Argentine group named it hypertensin, and called …

New agents in treatment of hyperkalemia: an opportunity to optimize use of RAAS inhibitors for blood pressure control and organ protection in patients with chronic …

A Rastogi, F Arman, S Alipourfetrati - Current hypertension reports, 2016 - Springer
Abstract Purpose of Review The overactive renin-angiotensin-aldosterone system (RAAS)
plays an important part in many pathologic conditions including hypertension, heart failure …

Клеточные, молекулярные и структурные механизмы ремоделирования левого желудочка при сердечной недостаточности

АН Беловол, ИИ Князькова - 2013 - repo.knmu.edu.ua
В представленном обзоре рассмотрены основные изменения миокарда
(архитектоника миокарда, внеклеточный матрикс) при ремоделирования сердца и …

A short history of the renin-angiotensin system

R Igic - Acta Medica Saliniana, 2009 - saliniana.com.ba
The renin-angiotesin system (RAS) was initially recognized as the body’ s most powerful
hormone system for controlling body fluid volumes and arterial pressure. Then, it was shown …

Up-regulation of TGF-β via the activation of extracellular signal-regulated kinase 1 and 2 induced by prorenin in human renal mesangial cells

W Song, Y Zhang, C Jia, L Ren… - Molecular …, 2012 - spandidos-publications.com
Prorenin is thought to be an inactive precursor of renin. This study investigated whether
human prorenin was capable of activating the (pro) renin receptors [(P) RRs], leading to the …

How little aldosterone is able to raise blood pressure?

E Ritz - Clinical Journal of the American Society of Nephrology, 2009 - journals.lww.com
After its first description, primary aldosteronism was long felt to be a rare condition (1). More
recently, a debate has been ongoing about the true prevalence of primary …

Inhibitory enzymu konwertującego angiotensynę i sartany: czy wyniki badań opublikowane w 2008 roku zmienią codzienną praktykę?

P Jankowski, D Czarnecka - Nadciśnienie Tętnicze, 2008 - ruj.uj.edu.pl
abstrakt w j. polskim: Od wprowadzenia sartanów do praktyki lekarskiej zarówno w Polsce,
jak iw innych krajach trwa dyskusja czy ta klasa leków, czy raczej inhibitory enzymu …

ACE-inhibitors and sartans-will large trials results published in 2008 change our every-day clinical practice?

P Jankowski, D Czarnecka - Arterial Hypertension, 2008 - journals.viamedica.pl
Sartans have been available for over 10 years. However, the debate concerning the
adventage of sartans vs ACE inhibitors is still ongoing. Recently published results of large …

[引用][C] 肾素原及其受体的研究进展

杨晓慧, 卢新政 - 中国病理生理杂志, 2010

[PDF][PDF] 心血管・腎臓疾患における新規生理活性物質の役割の検討

廣瀬卓男 - 2009 - tohoku.repo.nii.ac.jp
略語 英語 日本語 (P) RR(pro) renin receptor(プロ) レニン受容体 18S rRNA 18S ribosomal
RNA 18S リボソーム RNA 5/6NPX 5/6 nephrectomized 5/6 腎摘腎不全 95% CI 95 …